提高心脏再同步化治疗反应性进展  

Improve the Response of Cardiac Resynchronization Therapy

作　　者：万小倩 孙磊[1] 顾翔[1] WAN Xiaoqian;SUN Lei;GU Xiang(Northern Jiangsu People’s Hospital,Yangzhou 225001,Jiangsu,China;Graduate School of Dalian Medical University,Dalian 116044,Liaoning,China)

机构地区：[1]苏北人民医院,江苏扬州225001 [2]大连医科大学研究生院,辽宁大连116044

出　　处：《心血管病学进展》2023年第6期486-490,共5页Advances in Cardiovascular Diseases

摘　　要：心脏再同步化治疗(CRT)的出现,极大地缓解了一部分心力衰竭患者的症状,但是,并非所有进行CRT的患者都能有良好的反应性。患者的选择、植入部位及器械的选择、设备程控和随访等因素均可影响CRT反应性。因此现综述可能提高CRT反应性的相关因素。The emergence of cardiac resynchronization therapy(CRT)has greatly alleviated the symptoms of some patients with heart failure,but not all patients with CRT implantation can have a good reactivity.Factors such as patient selection,implantation site and device selection,equipment program control and follow-up can affect CRT reactivity.Therefore,this paper reviews the related factors that may improve the reactivity after CRT.

关 键 词：心力衰竭 心脏再同步化治疗 心电图 左束支区域起搏 

分 类 号：R541.6[医药卫生—心血管疾病]